Kurm Pharma ApS: Financial statements 2025
CVR: 39181274
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Kurm Pharma ApS (CVR 39181274) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity in the 2025 report amounted to DKK 1,813,033. The solvency ratio was 35.5%.
- Gross Profit
- DKK -2,598,150
- Profit/Loss
- DKK -1,978,646
- Equity
- DKK 1,813,033
- Total Assets
- DKK 5,102,762
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -2.6 mio. | -2 mio. | 1.8 mio. | 0 |
| 2024 | - | 331 t. | 602 t. | 4.1 mio. | - |
| 2023 | - | 91 t. | 242 t. | 3.5 mio. | - |
| 2022 | - | 459 t. | 333 t. | 3.2 mio. | - |
| 2021 | - | 2.6 mio. | 2 mio. | 3.1 mio. | - |
Official annual report
How creditworthy is Kurm Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Kurm Pharma ApS has published its annual report for 2024. Gross profit came to DKK 331,133, and the net result was DKK 602,189.
As of January 20, 2025, Allan Christensen has joined the board of directors of Kurm Pharma ApS.
About Kurm Pharma ApS
Kurm Pharma ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jacob Gjelstrup and Jesper Gjelstrup. The board consists of Steen Nordstrøm (chair), Allan Christensen, Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Fitzrovia ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity in the 2025 report amounted to DKK 1,813,033.